Parkinson's Disease Trial, Not Yet Recruiting NCT07630792 Sponsor: Bezmialem Vakif University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07630792
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with idiopathic Parkinson's disease (a specific form of Parkinson's not caused by another condition).
  • People whose Parkinson's disease falls within a mild to moderate range of severity, based on a standard rating scale called the Hoehn and Yahr scale (stages 1 to 3).
  • People who score 21 or higher on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA).
  • People who are able to use a smartphone, tablet, or computer.
  • People who have access to the internet and have basic skills for using digital devices.
  • People who take part in activities outside the home on at least 3 days per week.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with a neurological condition other than idiopathic Parkinson's disease.
  • People whose Parkinson's disease medication is changed or adjusted at any point during the study.
  • People who have previously had deep brain stimulation (a surgical treatment involving a device implanted in the brain).
  • People who have a vision or hearing problem that would prevent them from taking part in the treatment or assessments.
  • People who have a serious heart, bone and joint, lung, or other major health condition that means exercise would not be safe for them.
  • People who have been diagnosed with severe depression, a psychotic disorder, or a psychiatric illness that is not well managed.
  • People who have taken part in another structured physiotherapy or rehabilitation program specifically for Parkinson's disease within the last three months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Bezmialem Vakif University
Registry
ClinicalTrials.gov
Start date
20 June 2026
Est. completion
30 December 2027

Primary endpoints

Biodex Balance System; Movement Disorder Society-Unified Parkinson's Disease Rating Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov